Promentis Pharmaceuticals, Inc., a Milwaukee company co-founded by Drs. David Baker and John Mantsch, professors of biomedical sciences in the College of Health Sciences, has raised $2.9 million in Series B financing. The company, which develops drugs to treat schizophrenia and other central nervous system disorders, will use the funds to bring two of the compounds into clinical trials for humans within the next two years.
Two Marquette College of Health Sciences programs recently made significant leaps in U.S. News and World Report’s 2013 rankings. The doctoral physical therapy program is ranked 12th nationally, up from 19th, and the graduate program in speech-language pathology is ranked 62nd nationally, up from 72nd — the highest rankings ever achieved by either program.